Your browser doesn't support javascript.
loading
CDH13 is a prognostic biomarker and a potential therapeutic target for patients with clear cell renal cell carcinoma.
Shao, Yuan; Li, Wenxia; Zhang, Lin; Xue, Bo; Chen, Yongquan; Zhang, Zikuan; Wang, Dongwen; Wu, Bo.
Afiliación
  • Shao Y; Department of Urology, The Second Hospital of Tianjin Medical University Tianjin 300070, China.
  • Li W; Shanxi Medical University Taiyuan 030001, Shanxi, China.
  • Zhang L; Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University Tianjin 300350, China.
  • Xue B; Shanxi Medical University Taiyuan 030001, Shanxi, China.
  • Chen Y; Shanxi Medical University Taiyuan 030001, Shanxi, China.
  • Zhang Z; Shanxi Medical University Taiyuan 030001, Shanxi, China.
  • Wang D; Shanxi Medical University Taiyuan 030001, Shanxi, China.
  • Wu B; Shanxi Medical University Taiyuan 030001, Shanxi, China.
Am J Cancer Res ; 12(10): 4520-4544, 2022.
Article en En | MEDLINE | ID: mdl-36381315
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China